Search research articles
Contact Us
Filters
Showing results (31-40 of 365) with videos related to
Page
of 37
Sort By:
Expert Review of Anticancer Therapy
|
November 1, 2016
Experience with trabectedin + pegylated liposomal doxorubicin for recurrent platinum-sensitive ovarian cancer unsuited to platinum rechallenge
Nicoletta Colombo, Anne-Claire Hardy-Bessard, Gabriella Ferrandina, et al.
Cancer Treatment Reviews
|
December 4, 2013
Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedin
Andrés Poveda, Isabelle Ray-Coquard, Ignacio Romero, et al.
Immunotherapy
|
July 9, 2013
Are monoclonal antibodies a safe treatment for cancer during pregnancy?
Maria Anna Sarno, Rosanna Mancari, Hatem A Azim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 24, 2011
Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors
Philippe Morice, Dominik Denschlag, Alex Rodolakis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2023
Myeloid neoplasms post PARP inhibitors for ovarian cancer
Giuseppe Caruso, Federica Gigli, Gabriella Parma, et al.
Gynecologic Oncology
|
August 31, 2007
Chemo-conization in early cervical cancer
Fabio Landoni, Gabriella Parma, Michele Peiretti, et al.
Cancers
|
November 27, 2021
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?
Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, et al.
Journal of Surgical Oncology
|
August 2, 2019
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study
Jacob Korach, Nicoletta Colombo, Cesar Mendiola, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 3, 2018
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
Frédéric Selle, Nicoletta Colombo, Jacob Korach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
Reply to P.-H. Luo et al
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, et al.
Page
of 37
Search research articles
Search
Showing results (31-40 of 365) with videos related to
Sort By:
Page
of 37
Expert Review of Anticancer Therapy
|
November 1, 2016
Experience with trabectedin + pegylated liposomal doxorubicin for recurrent platinum-sensitive ovarian cancer unsuited to platinum rechallenge
Nicoletta Colombo, Anne-Claire Hardy-Bessard, Gabriella Ferrandina, et al.
Cancer Treatment Reviews
|
December 4, 2013
Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedin
Andrés Poveda, Isabelle Ray-Coquard, Ignacio Romero, et al.
Immunotherapy
|
July 9, 2013
Are monoclonal antibodies a safe treatment for cancer during pregnancy?
Maria Anna Sarno, Rosanna Mancari, Hatem A Azim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 24, 2011
Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors
Philippe Morice, Dominik Denschlag, Alex Rodolakis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2023
Myeloid neoplasms post PARP inhibitors for ovarian cancer
Giuseppe Caruso, Federica Gigli, Gabriella Parma, et al.
Gynecologic Oncology
|
August 31, 2007
Chemo-conization in early cervical cancer
Fabio Landoni, Gabriella Parma, Michele Peiretti, et al.
Cancers
|
November 27, 2021
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?
Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, et al.
Journal of Surgical Oncology
|
August 2, 2019
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study
Jacob Korach, Nicoletta Colombo, Cesar Mendiola, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 3, 2018
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
Frédéric Selle, Nicoletta Colombo, Jacob Korach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
Reply to P.-H. Luo et al
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, et al.
Page
of 37